Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl 4-(4-hydroxyanilino)piperidine-1-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

851702-96-0

Post Buying Request

851702-96-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

851702-96-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 851702-96-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,7,0 and 2 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 851702-96:
(8*8)+(7*5)+(6*1)+(5*7)+(4*0)+(3*2)+(2*9)+(1*6)=170
170 % 10 = 0
So 851702-96-0 is a valid CAS Registry Number.

851702-96-0Downstream Products

851702-96-0Relevant academic research and scientific papers

Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship

Vianello, Paola,Sartori, Luca,Amigoni, Federica,Cappa, Anna,Fagá, Giovanni,Fattori, Raimondo,Legnaghi, Elena,Ciossani, Giuseppe,Mattevi, Andrea,Meroni, Giuseppe,Moretti, Loris,Cecatiello, Valentina,Pasqualato, Sebastiano,Romussi, Alessia,Thaler, Florian,Trifiró, Paolo,Villa, Manuela,Botrugno, Oronza A.,Dessanti, Paola,Minucci, Saverio,Vultaggio, Stefania,Zagarrí, Elisa,Varasi, Mario,Mercurio, Ciro

, p. 1693 - 1715 (2017)

The balance of methylation levels at histone H3 lysine 4 (H3K4) is regulated by KDM1A (LSD1). KDM1A is overexpressed in several tumor types, thus representing an emerging target for the development of novel cancer therapeutics. We have previously describe

THIENOPYRROLES AS HISTONE DEMETHYLASE INHIBITORS

-

Page/Page column 54; 55, (2016/05/02)

The present application relates to thienopyrrole derivatives, compounds of Formulae (I) and (la), wherein R, R1, R2 and R3 are as defined in the specification, pharmaceutical compositions containing such compounds and to t

2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS

-

Page/Page column 636, (2008/06/13)

The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(C

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 851702-96-0